top of page

Day 2: Exit Strategies & Scaling Startups

Navigating the complex landscape of scaling and exit strategies remains a significant challenge for Healthtech, MedTech, and DeepTech startups. Achieving product-market fit, ensuring scalability, and understanding the nuances of mergers and acquisitions are critical components for success. This block focuses on the art of scaling startups, exploring various exit strategies, and providing insights into cross-border deals and emerging markets. Attendees will gain valuable knowledge on how to effectively scale their ventures and prepare for successful exits.

Core Problem:

Even promising startups often fail to scale or exit successfully — especially in regulated sectors like healthtech — due to misaligned incentives, lack of operational support, or poor cross-border strategies.

 
Core Challenges:

  • How can investors support better exit-readiness in their portfolios?

  • What models are working for M&A and IPOs across medtech/biotech?

  • How do you manage risk across borders and regulatory jurisdictions (EU/US/Asia)?

  • How DeepTech investors are planning for liquidity: licensing, partnerships, and M&A.

 
Key Topics Covered:

  • Best practices from successful exits (investors & founders).

  • Cross-border scale: case studies in health and biotech.

  • Investor strategies for de-risking digital health, biotech, longevity.

  • How AI is enabling diagnostics, care delivery, and investment decisioning.

  • AI as an exit accelerator: building defensible IP and valuation uplift.

 
Detailed Activities:

Block 3: Scaling Startup, Exits & IPOs

  • Keynote: “The Art of a Successful Exit” — Designing M&A and IPO strategies with strategic and financial buyers in mind.

  • Panel: “Founder-Investor Perspectives on Exits” — Aligning outcomes across the cap table.

  • Reverse Pitch: Investors walk through case studies of successful exits and learnings.

​

Block 4: Digital Health, Longevity, Biotech & MedTech Innovation

  • Keynote: “Why Longevity, MedTech, and Digital Health Are the Next Frontier” — The convergence of aging, tech, and system demand.

  • Panel: “Scaling with Integrity” — Navigating global regulation, from CE to FDA and beyond.

  • Startup Pitch Session: Healthtech, biotech, DeepTech and MedTech ventures with traction and scale potential.

 
Female-Focused Integration:

This block includes featured contributions from a female investor experienced in scaling and exiting biotech ventures, and a founder who successfully navigated acquisition in MedTech.

 

Panel + Networking:

This segment emphasizes operational truth-telling and strategic discipline. Investors will benefit from exposure to scale-ready companies, insights into high-stakes deal dynamics, and co-investment dialogue with FOs and growth funds targeting health innovation.

bottom of page